Johnson & Johnson said that its single-shot coronavirus vaccine neutralises the fast-spreading delta variant and provides durable protection against infection more broadly, APA reports citing Sputnik.
The company said in a statement Thursday that recipients of its vaccine produced strong neutralising antibodies over the course of at least eight months against all variants including delta.